Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Hospital readmissions present a complex, costly issue for US cardiologists Erik Swain
-
- How cardiologists are paid L. Samuel Wann, MD, MACC, FESC
- Sapien XT FDA approved for high-risk, inoperable patients
- FDA: No clear link between olmesartan, CV risk among patients with diabetes
- Antidepressant use during pregnancy not linked to risk for infant cardiac defects
- Diabetes, vascular disease connection differs by phenotype
- Evidence suggests causal link between vitamin D deficiency, hypertension
- Gender-specific research, strategies may improve accuracy of ischemic heart disease diagnosis in women
- HPS2-THRIVE published: Niacin did not benefit patients with vascular disease
-
- Prophylactic ICDs improved survival in patients with less severe HF
- Regular use of some NSAIDs moderately increased CV risk in postmenopausal women
- Franz H. Messerli, MD: A leading authority on hypertension management
- 3-D quantitative coronary angiography reliably identifies occult severe lesions
- DAPT duration after endovascular intervention did not affect major adverse events
- Low operator PCI volume linked to worse outcomes, higher cost
- Orbital atherectomy improved long-term outcomes in high-risk patients
- RadiCure: Device reduced radiation exposure during cardiac catheterization
-
- Smart technology use common, beneficial in congenital cath lab
- Smokers more vulnerable to arterial plaque ruptures
- Trial Scorecard: BtB
- Trial Scorecard: GARY
- Trial Scorecard: IQ-CATEGORIZE
- Trial Scorecard: MrOS
- Trial Scorecard: OACIS
- Trial Scorecard: SLIMM-T2D
-
- Trial Scorecard: TESLA
- Trial Scorecard: VIRGO